Dietary treatment of the irritable bowel syndrome

被引:27
作者
Whorwell P. [1 ]
Lea R. [1 ]
机构
[1] Education and Research Centre, Wythenshawe Hospital
关键词
Irritable Bowel Syndrome; Celiac Disease; Food Allergy; Sodium Cromoglycate; Food Intolerance;
D O I
10.1007/s11938-004-0017-1
中图分类号
学科分类号
摘要
Most patients with functional gastrointestinal disorders report that food ingestion appears to exacerbate their symptoms and consequently conclude that they have some form of gastrointestinal food allergy or intolerance. Dietary management of functional gastrointestinal conditions is an attractive therapeutic option for the patient and physician alike because it is safe and economical and empowers the patient to help themselves. However, in practice, dietary manipulation frequently yields rather disappointing results. Exclusion diets can be helpful, but are labor intensive and occasionally can be very restrictive. Laboratory testing for immunoglobulin E food antibodies usually is not helpful, except in a small subgroup of patients with diarrhea, predominant irritable bowel syndrome (IBS), and atopy. There is some preliminary evidence to suggest that elimination diets based on immunoglobulin G food antibody testing may possibly have therapeutic potential in IBS, but this requires confirmation. Copyright © 2004 by Current Science Inc.
引用
收藏
页码:307 / 316
页数:9
相关论文
共 74 条
[11]  
Guthrie E., Creed F., Dawson D., Tomenson B., A controlled trial of psychological treatment for the irritable bowel syndrome, Gastroenterology, 100, pp. 450-457, (1991)
[12]  
Jackson J.L., O'Malley P.G., Tomkins G., Et al., Treatment of functional gastrointestinal disorders with antidepressant medications: A meta-analysis, Am. J. Med., 108, pp. 65-72, (2000)
[13]  
Whorwell P.J., Prior A., Faragher E.B., Controlled trial of hypnotherapy in the treatment of severe refractory irritable-bowel syndrome, Lancet, 2, pp. 1232-1234, (1984)
[14]  
Lea R., Whorwell P.J., Serotonergic agents in the treatment of functional gastrointestinal disorders, Curr. Treat Options Gastroenterol., 5, pp. 293-300, (2002)
[15]  
Dainese R., Galliani E.A., De Lazzari F., Et al., Discrepancies between reported food intolerance sensitization test findings in irritable bowel syndrome patients, Am. J. Gastroenterol., 94, pp. 1892-1897, (1999)
[16]  
Young E., Stoneham M.D., Petruckevitch A., Et al., A population study of food intolerance, Lancet, 343, pp. 1127-1130, (1994)
[17]  
O'Sullivan M., Clayton N., Breslin N.P., Et al., Increased mast cells in the irritable bowel syndrome, Neurogastroenterol. Motil., 12, pp. 449-457, (2000)
[18]  
Weston A.P., Biddle W.L., Bhatia P.S., Miner Jr. P.B., Terminal ileal mucosal mast cells in irritable bowel syndrome, Dig. Dis. Sci., 38, pp. 1590-1595, (1993)
[19]  
Petitpierre M., Gumowski P., Girard J.P., Irritable bowel syndrome hypersensitivity to food, Ann. Allergy, 54, pp. 538-540, (1985)
[20]  
Barau E., Dupont C., Modifications of intestinal permeability during food provocation procedures in pediatric irritable bowel syndrome, J. Pediatr. Gastroenterol. Nutr., 11, pp. 72-77, (1990)